Related Experiment Video

Updated: May 12, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

[Tako-Tsubo cardiomyopathy]

Nicolas Mansencal1, Olivier Dubourg

  • 1Assistance publique-Hôpitaux de Paris (AP-HP), hôpital Ambroise-Paré, centre de référence pour les maladies cardiaques héréditaires, université de Versailles-Saint-Quentin (UVSQ), pôle V thorax vasculaire digestif métabolisme, 92100 Boulogne, France. nicolas.mansencal@apr.aphp.fr

Presse Medicale (Paris, France : 1983)
|April 16, 2013
PubMed

Insights

Tako-Tsubo cardiomyopathy, a transient left ventricular dysfunction, often mimics heart attacks and primarily affects postmenopausal women. Diagnosis relies on specific criteria and imaging, with full recovery being the typical outcome.

Area of Science:

  • Cardiology
  • Internal Medicine

Context:

  • Tako-Tsubo cardiomyopathy (TTC) presents as a transient left ventricular systolic dysfunction, often mimicking acute coronary syndromes.
  • While stress is a common trigger, it is not universally present in all cases.

Purpose:

  • To outline the diagnostic criteria and assessment methods for Tako-Tsubo cardiomyopathy.
  • To describe the typical presentation, affected demographic, and expected prognosis of TTC.

Summary:

  • Diagnosis is established using the Mayo Clinic criteria, involving electrocardiogram, biomarkers, echocardiography, coronary angiography, and cardiac MRI.
  • The hallmark finding is transient left ventricular dysfunction with characteristic apical and mid-ventricular akinesia.
  • Potential acute complications require systematic evaluation.

Impact:

  • Understanding TTC's diagnostic pathway and characteristic features aids in accurate identification and management.
  • Recognizing the typical complete recovery of left ventricular function confirms the diagnosis and guides follow-up care.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...